|
Role of ASXL1 mutations in myeloid malignancies
|
5K08CA160647-05
|
$169,884
|
$169,884
|
ABDEL-WAHAB, OMAR
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
3R01CA140622-05S1
|
$54,171
|
$54,171
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
5R01CA140622-05
|
$388,425
|
$388,425
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-15
|
$1,428,925
|
$171,471
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$21,688
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$76,793
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$198,927
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$307,453
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$22,899
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$260,823
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$24,673
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$8,066,901
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Investigating the potential role of NADPH oxidase 2 in regulating the biology of
|
1F31CA196330-01
|
$28,804
|
$28,804
|
ADANE, BINIAM
|
UNIVERSITY OF COLORADO DENVER
|
|
Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target
|
5R00CA151670-04
|
$248,585
|
$248,585
|
AGARWAL, ANUPRIYA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$29,488
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
1R01CA194923-01
|
$457,533
|
$457,533
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-07
|
$381,375
|
$381,375
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mechanisms of T cell leukemia induction and maintenance
|
5R01CA149655-05
|
$340,155
|
$340,155
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
5R01CA169784-02
|
$355,993
|
$355,993
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$430,051
|
$43,005
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 - 10527
|
$854,646
|
$341,858
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
$26,160
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S1
|
$34,031
|
$3,063
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S2
|
$250,000
|
$22,500
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S3
|
$124,997
|
$11,250
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-07
|
$1,495,000
|
$134,550
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$51,835
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
1R01CA184137-01A1
|
$362,569
|
$362,569
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,717,771
|
$549,687
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
$4,162
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
$77,350
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
$5,000
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
$12,445
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$679,152
|
$679,152
|
Anderson, Stephen
|
CCR (NCI)
|
|
Targeting the c-Met/HGF Axis in Acute Myeloid Leukemia
|
5R03CA188236-02
|
$79,250
|
$79,250
|
ANDREADIS, CHARALAMBOS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$261,157
|
$261,157
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$261,157
|
$261,157
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$522,314
|
$261,157
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$261,157
|
$130,578
|
Aplan, Peter
|
CCR (NCI)
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
5R01CA165277-04
|
$410,314
|
$410,314
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Adult Leukemia Research Center
|
5P01CA018029-40
|
$4,225,448
|
$3,422,613
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
5R01CA160433-04
|
$336,150
|
$336,150
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting to Epigenetic Modications in ALL
|
5R01CA176745-05
|
$402,250
|
$402,250
|
ARMSTRONG, SCOTT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-21
|
$4,271,782
|
$854,356
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$38,443
|
$38,443
|
Arthur, Diane
|
CCR (NCI)
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
ZIA SC 010282
|
$76,885
|
$76,885
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$653,524
|
$588,172
|
Arthur, Diane
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$6,500
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Leukemia for this search: $246,937,146
|